Can I Take Vitamin B6 with Vyvanse?

What Is the Interaction Between Vitamin B6 and Vyvanse?

No published pharmacokinetic drug interaction exists between lisdexamfetamine and vitamin B6. The two compounds do not compete for the same hepatic enzymes, plasma proteins, or renal transporters. Vyvanse is hydrolyzed by red blood cell peptidases to release d-amphetamine, a process that pyridoxine does not alter [1].

Why the Question Arises

Vitamin B6 comes up in ADHD circles for two reasons. First, some practitioners use high-dose B6 plus magnesium combinations (the "B6/Mg" protocol) as an adjunct or alternative to stimulants, based largely on small open-label trials in children [2]. Second, patient forums often flag B6 as a potential "dopamine booster," raising concern about additive stimulant effects.

The dopamine-synthesis pathway does use pyridoxal-5-phosphate (PLP, the active coenzyme form of B6) as a cofactor for aromatic L-amino acid decarboxylase, the enzyme that converts L-DOPA to dopamine [3]. In theory, very high B6 could modestly increase dopamine synthesis. In practice, the enzyme is not rate-limited by PLP availability at normal or moderate-supplement B6 levels, so a meaningful pharmacodynamic interaction is unlikely at doses below 200 mg/day.

What the Prescribing Information Says

The FDA-approved prescribing information for Vyvanse lists no interaction with vitamin B6 or pyridoxine [4]. The label does note that urine acidification reduces amphetamine reabsorption in the renal tubule, but B6 does not meaningfully alter urinary pH at supplemental doses.

Pharmacology of Lisdexamfetamine: What B6 Cannot Change

Understanding why B6 is unlikely to cause a direct interaction requires a brief look at how Vyvanse actually works.

How Vyvanse Is Activated

Lisdexamfetamine dimesylate is an inactive prodrug. After oral ingestion it is absorbed intact, enters red blood cells, and undergoes enzymatic cleavage of the lysine amino acid to release d-amphetamine [1]. This hydrolysis step does not rely on cytochrome P450 enzymes. Pyridoxine does not inhibit or induce the relevant peptidases. The resulting d-amphetamine then enters the CNS, reverses dopamine and norepinephrine transporters, and releases catecholamines into the synapse.

Urinary pH and Amphetamine Clearance

Amphetamine is a weak base (pKa approximately 9.9). Acidic urine traps the ionized form in the renal tubule and speeds excretion; alkaline urine does the opposite. Vitamin B6 has no meaningful effect on urinary pH at doses used in supplements, so it does not extend or shorten Vyvanse's effective duration [5].

Protein Binding and Distribution

D-amphetamine is approximately 20% protein-bound in plasma. Pyridoxal-5-phosphate does bind to albumin, but not at sites that displace amphetamine to a clinically relevant degree [6]. No displacement interaction has been documented.

The Real Risk: High-Dose Vitamin B6 Neuropathy

The safety concern with vitamin B6 in any patient, including those on Vyvanse, is not an interaction with the drug. It is the independent neurotoxic potential of high-dose pyridoxine itself.

Establishing the Dose Threshold

The NIH Office of Dietary Supplements sets the tolerable upper intake level (UL) for adults at 100 mg/day from supplements and food combined [7]. This figure is conservative; the European Food Safety Authority (EFSA) places its UL at 25 mg/day for supplemental pyridoxine, citing a broader review of case reports and observational data [8].

Sensory peripheral neuropathy from B6 was first described systematically by Schaumburg et al. In a 1983 case series of seven adults who developed ataxia and limb numbness after taking 2,000 mg/day or more for months [9]. Later case reports documented neuropathy at lower doses. A review by Gdynia et al. Identified cases at sustained intakes as low as 200 mg/day over several months [10].

Symptoms to Watch For

Symptoms of pyridoxine-induced neuropathy include numbness, tingling, or burning in the hands and feet, unsteady gait, and in severe cases reduced proprioception. These symptoms are typically reversible after discontinuation of high-dose B6, though recovery may take weeks to months [9].

Vyvanse itself can cause peripheral vasoconstriction (Raynaud-like effects) and, rarely, peripheral neuropathy has been noted anecdotally in case reports of long-term stimulant use. If a patient taking Vyvanse also takes high-dose B6 and develops limb numbness, attributing the symptom to the correct cause requires clinical assessment.

The 25 mg to 100 mg Daily Window

Most multivitamins contain 1.3 to 2 mg of B6, covering the recommended dietary allowance (RDA) of 1.3 to 1.7 mg/day for adults [7]. Stand-alone B6 supplements typically come in 25 mg, 50 mg, or 100 mg tablets. At 25 to 100 mg/day, published evidence does not show clinically significant neuropathy risk, and no interaction with Vyvanse is expected. Doses above 200 mg/day sustained over weeks carry documented neuropathy risk and should not be self-prescribed by any patient without physician supervision.

Specific Populations Who Need Extra Attention

Patients Also Taking Isoniazid, Hydralazine, or Penicillamine

These three drugs antagonize pyridoxine through different mechanisms. Isoniazid (used for tuberculosis) forms a hydrazone complex with pyridoxal, depleting active B6 and causing a drug-induced B6 deficiency that can produce peripheral neuropathy [11]. Patients on isoniazid are routinely co-prescribed 25 to 50 mg/day of pyridoxine to prevent this complication. If such a patient is also on Vyvanse, the B6 supplementation is medically appropriate and poses no added Vyvanse-specific risk.

Hydralazine (antihypertensive) and penicillamine (used in Wilson's disease and rheumatoid arthritis) also deplete B6 by forming Schiff base adducts with pyridoxal [12]. Again, the interaction is between those drugs and B6, not between B6 and Vyvanse.

Pregnant Women with ADHD

The RDA for B6 rises to 1.9 mg/day during pregnancy [7]. Prenatal vitamins typically contain 2 to 10 mg. The first-line treatment for nausea and vomiting of pregnancy is doxylamine plus pyridoxine (Diclegis/Bonjesta), providing 10 to 20 mg B6 per day. Vyvanse is FDA pregnancy category not assigned (replaced by the current labeling system) but carries warnings about premature birth and neonatal withdrawal; stimulants in pregnancy require specialist oversight regardless of B6.

Children and Adolescents

The UL for B6 in children aged 9 to 13 years is 60 mg/day; for adolescents 14 to 18 years it is 80 mg/day [7]. Vyvanse is FDA-approved for ADHD in patients aged 6 years and older [4]. Parents supplementing a child with B6 (common in autism-spectrum co-management) should confirm dosing with the prescribing clinician.

Practical Dosing and Timing Guidance

The following framework reflects HealthRX clinical team recommendations based on published pharmacology and guideline thresholds. It has not been tested in a prospective trial.

Dose Tiers for B6 with Vyvanse

Tier 1: Dietary and multivitamin amounts (1.3 to 10 mg/day) No interaction concern. Take as normal, no timing restriction relative to Vyvanse.

Tier 2: Low-dose standalone supplement (25 to 100 mg/day) No direct drug interaction expected. Inform your prescriber. No specific timing separation from Vyvanse is pharmacologically necessary, though taking supplements with or after food rather than immediately before a morning dose of Vyvanse is reasonable standard practice.

Tier 3: Moderate-to-high dose (100 to 200 mg/day) Approaches the conservative NIH UL. Should be discussed with a physician. Monitor for early neuropathy symptoms (tingling in hands or feet). No Vyvanse-specific interaction, but the independent neuropathy risk warrants oversight.

Tier 4: Very high dose (above 200 mg/day) Documented neuropathy risk from B6 alone [9][10]. Do not self-prescribe at these doses. If a clinician prescribes this range (e.g., for pyridoxine-dependent epilepsy), Vyvanse dosing adjustments are not required based on current evidence, but neurological monitoring should be in place.

Timing Separation: Is It Necessary?

No pharmacokinetic reason exists to separate B6 and Vyvanse doses by time. Unlike calcium or antacids (which alkalize urine and may modestly extend amphetamine half-life [5]), B6 does not alter gastric pH, urinary pH, or CYP enzyme activity. Taking them together at breakfast is acceptable.

What the Evidence Says About B6 and ADHD Symptoms

Some patients and parents explore B6 hoping it will improve ADHD symptoms alongside or instead of medication. The evidence is weak.

A 2011 Cochrane review by Nye and Brice examined six randomized trials of B6 combined with magnesium in children with ADHD or autism-spectrum presentations [2]. The review found insufficient evidence to recommend the combination, citing methodological limitations including small sample sizes (range 10 to 52 per trial) and short follow-up. No trial reported serious adverse events from B6 at doses studied (typically 0.6 to 1 mg/kg/day in children).

A 2017 meta-analysis by Heilskov Rytter et al. Examining micronutrient supplementation in ADHD found that single-nutrient B6 supplementation produced no statistically significant reduction in ADHD rating scale scores compared with placebo [13]. The American Academy of Pediatrics' 2019 ADHD clinical practice guideline does not recommend B6 supplementation as a primary or adjunct ADHD treatment [14].

Taking Vyvanse plus B6 hoping for a synergistic ADHD effect is not supported by current trial data. Patients should use B6 only for documented deficiency, for co-prescribed indications (such as isoniazid co-therapy), or under physician guidance for specific conditions.

Monitoring and What to Tell Your Doctor

Open communication with your prescriber is the most important safety step, not because the interaction is dangerous but because your full supplement list should be documented in your medical record.

What to Report Immediately

Contact your prescriber if you develop any of the following after starting or increasing B6:

• Numbness, tingling, or burning in the hands, feet, or lips
• Unsteady walking or balance problems
• New or worsening sensitivity to touch
• Worsening of any Vyvanse side effects (insomnia, palpitations, appetite loss)

Lab Monitoring

Routine plasma pyridoxal-5-phosphate levels are not needed for patients taking B6 below 100 mg/day. For patients taking 100 to 200 mg/day long-term, a baseline PLP level (normal range approximately 20 to 125 nmol/L) and periodic neurological symptom review are reasonable [7]. Vyvanse does not require additional lab monitoring beyond what is already indicated for stimulant therapy (blood pressure, heart rate, weight in children).

Interactions with Other Supplements Commonly Paired with Vyvanse

Vitamin B6 is often taken as part of a B-complex or combined micronutrient supplement. A few co-ingredients deserve mention:

Magnesium: Frequently paired with B6 in the "B6/Mg" ADHD protocol. No interaction with Vyvanse's pharmacokinetics. Magnesium oxide (a common cheap form) is alkaline and could in theory mildly shift urinary pH, but the effect is small and clinically negligible at typical supplement doses of 200 to 400 mg elemental magnesium [5].

Vitamin C (ascorbic acid): Acidifies urine and may modestly reduce amphetamine reabsorption, shortening effective duration. This is the more clinically relevant supplement interaction with Vyvanse, not B6 [5].

Zinc: Some ADHD trials suggest zinc may improve stimulant response at 15 to 30 mg/day. No direct interaction with B6 or Vyvanse [13].

Summary of Key Points

Vitamin B6 at standard supplement doses (up to 100 mg/day) does not interact with Vyvanse pharmacokinetically or in a clinically meaningful pharmacodynamic way. The risk from B6 is its own dose-dependent neuropathy, documented in case series at sustained intakes above 200 mg/day [9][10]. Most patients taking Vyvanse for ADHD or binge eating disorder can safely take a standard B6 supplement or multivitamin without adjusting their Vyvanse dose, timing, or monitoring schedule. The European Food Safety Authority's lower UL of 25 mg/day for supplemental pyridoxine is worth knowing if you are in a region that follows EFSA guidance [8].

Tell your prescriber your exact B6 dose. If you develop any limb numbness or tingling while on both, report it at your next visit or sooner.